Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.
about
Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin beta3Simian homologues of Epstein-Barr virusComplete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaMultipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1The first endogenous herpesvirus, identified in the tarsier genome, and novel sequences from primate rhadinoviruses and lymphocryptovirusesA BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes.Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients.Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinomaComplete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.An Epstein-Barr-related herpesvirus from marmoset lymphomas.Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virusEpstein-Barr virus and rheumatoid arthritis: is there a link?Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersEpstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.Secretion of Epstein-Barr virus-encoded BARF1 oncoprotein from latently infected B cells.Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.Infection of primary human monocytes by Epstein-Barr virus.Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.Epstein-Barr virus infection and nasopharyngeal carcinoma.Recent Advances on the Possible Neuroprotective Activities of Epstein-Barr Virus Oncogene BARF1 Protein in Chronic Inflammatory Disorders of Central Nervous System.Innate immune modulation in EBV infection.The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis.
P2860
Q22254038-9AC6BB1C-80B1-4B5A-B85C-DEF5D001B006Q24522326-2BE52279-6965-445B-8E4C-97F574CEBB38Q24540310-D71E2B25-AAFA-4AC6-B38E-21FBC0C20C6AQ26998401-ABE8540D-065E-4E2A-AC2D-8AD294141DC4Q27016002-61CD3171-5323-4818-BB59-0AAF4B44A27AQ27670894-A416DA53-F88F-44D2-ACEF-3B547629527DQ28657883-4BBB2CD2-33C5-42DA-B531-F90B4765F56EQ33632095-D5416244-265A-459C-ADA1-43C34B49BB5DQ33650938-EE059B55-6F42-4283-9218-FF86A3CFB00BQ33760249-BCED2305-51D2-4E89-AF63-55B48193B8E7Q34173615-75169196-1A16-4612-8851-02A3B745AD26Q34360303-FDE2EC4F-2F4B-410F-B44A-3DC4E8CB1251Q34539785-C1201D1A-6B56-4B07-803E-6104DA695723Q34656773-A3191B5F-71E2-43F9-8052-80C1F3311B96Q34742561-1D30C2C0-CADE-42A0-976E-D46B1E164B1DQ34896078-9AD93D8B-4A67-425C-961B-51EFA237A6DAQ35738744-2B4315E5-736C-4625-8BE2-00648339AB38Q36526103-A5C675C5-1844-43C2-9269-698A8F57B524Q36590231-66EC8543-61AC-4815-BAC3-EF7820F92606Q36622842-BF411DEE-1101-4B39-B198-DA0B81D8DCAFQ37449248-D22DEDA5-429A-4F12-A880-1EB569647034Q38133428-6FF2DFF5-78CF-4956-B8AB-702038769DCEQ39257792-4D49D6CF-CC32-4607-8250-2FEDAF5DB69FQ39296826-A5354812-2BCB-4479-B556-2FEF673B37B5Q39589786-035D426C-896B-403D-B85C-1CF6445F4AE6Q39630573-4005F100-6391-4DF3-A718-2E8DE28BCA92Q40046633-9C36FDD8-363D-4957-8DD2-1C2141E7933EQ41136819-057F378B-E675-4627-AB60-0614F9AEDF6AQ42702857-8F95A243-0C08-4E71-9E59-88084EA6CBC6Q54245037-481726E8-51E1-4E32-8F69-13F0394C10D9
P2860
Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@ast
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@en
type
label
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@ast
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@en
prefLabel
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@ast
Epstein-Barr virus BARF1 prote ...... retion from mononuclear cells.
@en
P2860
P1433
P1476
Epstein-Barr virus BARF1 prote ...... cretion from mononuclear cells
@en
P2093
P2860
P304
P577
1999-09-01T00:00:00Z